Yeawon Kim

Title: Yeawon Kim: Innovator in Kidney Disease Research

Introduction

Yeawon Kim is a prominent inventor based in St. Louis, MO (US). He has made significant contributions to the field of kidney disease research, focusing on innovative methods and compositions for treatment and detection.

Latest Patents

Yeawon Kim holds 2 patents that address critical issues related to endoplasmic reticulum (ER) stress-mediated kidney diseases. His latest patents include:

1. **Compositions and methods for treating and preventing endoplasmic reticulum (ER) stress-mediated kidney diseases** - This patent provides methods and compositions aimed at treating or preventing ER stress-mediated kidney diseases. The method involves administering a pharmaceutical composition that includes a therapeutically effective amount of an ER calcium channel stabilizing agent or an ER stress modulating agent, such as mesencephalic astrocyte-derived neurotrophic factor (MANF) or compound K201.

2. **Methods of detecting biomarkers of endoplasmic reticulum (ER) stress-associated kidney diseases** - This patent outlines methods for detecting biomarkers associated with ER stress-related kidney diseases. It also includes a method for treating such diseases in subjects.

Career Highlights

Yeawon Kim is affiliated with Washington University, where he conducts his research and development work. His innovative approaches have positioned him as a key figure in the medical research community, particularly in the area of kidney health.

Collaborations

He has collaborated with notable colleagues, including Ying Chen and Fumihiko Urano, to advance research in his field.

Conclusion

Yeawon Kim's work in developing treatments and detection methods for kidney diseases showcases his commitment to improving patient outcomes. His contributions are vital in the ongoing fight against kidney-related health issues.